Literature DB >> 4084329

Seronegative polyarthritis in giant cell arteritis.

W W Ginsburg, M D Cohen, S B Hall, R S Vollertsen, G G Hunder.   

Abstract

Nineteen of 520 patients with biopsy-proven giant cell arteritis were found to have persistent seronegative, symmetric polyarthritis with a mean joint count of 20 (swollen plus tender). In 9 patients in the onset of polyarthritis occurred prior to the diagnosis of giant cell arteritis, 3 had simultaneous onset, and 7 developed polyarthritis within 3 years after the onset of giant cell arteritis. Ten of the 19 patients demonstrated radiographic features of joint space narrowing and/or erosions. In 1 patient in a synovial biopsy was performed, revealing marked multinucleated giant cell infiltration. A persistent seronegative polyarthritis, although uncommon in giant cell arteritis, may be its presenting symptom. Other symptoms of giant cell arteritis should be sought in patients who exhibit this feature, especially in those whose arthritis begins at age 50 or older.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4084329     DOI: 10.1002/art.1780281208

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  3 in total

Review 1.  Giant cell arteritis, polymyalgia rheumatica, and late-onset rheumatoid arthritis: Can they be components of a single disease process in elderly patients?

Authors:  Cengiz Korkmaz; Pınar Yıldız
Journal:  Eur J Rheumatol       Date:  2017-02-24

2.  The HLA-DRB1 locus as a genetic component in giant cell arteritis. Mapping of a disease-linked sequence motif to the antigen binding site of the HLA-DR molecule.

Authors:  C M Weyand; K C Hicok; G G Hunder; J J Goronzy
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

3.  Late-onset systemic lupus erythematosus presenting as polymyalgia rheumatica.

Authors:  M Maragou; F Siotsiou; H Sfondouris; Z Nicolia; G Vayopoulos; P Dantis
Journal:  Clin Rheumatol       Date:  1989-03       Impact factor: 2.980

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.